FALLS CHURCH, Va., Nov. 1, 2018 /PRNewswire-PRWeb/ -- SOPs for the 21st Century is a highly-interactive, two-day workshop
Early bird pricing for SOPs for the 21st Century ends on Thursday, Nov. 8.
Are the SOPs written for the auditor, or to help the staff? Far too often, SOP documents end up reading like some complicated legal document when what employees really need is something they can quickly skim and digest every day.
This workshop provides an opportunity to hear from John Avellanet, an acknowledged SOP expert who's defended SOPs and policies to government inspectors and litigators alike, who will show practical techniques to streamline and simplify policies and procedures, all while strengthening compliance. And attendees will also share experiences and learn from fellow attendees who are confronting the same issues.
By attending this critical workshop and attendees will find out:
Attend this highly-interactive, two-day workshop that will teach the practical techniques needed for writing fast-read, flexible and compliant SOPs that will meet FDA requirements as well as today's globalized expectations.
Early bird pricing ends on Thursday, Nov. 8.
Meet the Presenter: John Avellanet, Founder Cerulean Associates LLC
John Avellanet is an award-winning FDA compliance expert known for his business-savvy, pragmatic advice and engaging speaking style. Mr. Avellanet was the lead author of several certification courses on Good Manufacturing Practices (GMP) and Quality System Regulation (QSR) supplier management for the US Regulatory Affairs Professional Society.
Conference Details SOPs for the 21st Century: Why Less is More **Presented by FDAnews and Cerulean Associates LLC ** Dec. 6-7, 2018 – Arlington, VA http://www.fdanews.com/sops
Tuition: Early Bird Pricing: $1,597 (available until Nov. 8, 2018) Regular Pricing: $1,797 (after Nov. 8, 2018) Significant team discounts are available.
Easy Ways to Register Online: http://www.fdanews.com/sops By phone: 888-838-5578 or 703-538-7600
About FDAnews FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
Subscribe to our Free Newsletters!